KATY PFIFFNER: Open Payments
NPI 1023665866 · FORT COLLINS, CO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,116 in 56 payments from 13 companies in 2025. Trend: 2023 $633 · 2024 $723 · 2025 $1,116
Food & beverage: $1,103Education: $14
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 9 | $274 |
| GlaxoSmithKline, LLC. | 7 | $194 |
| Regeneron Healthcare Solutions, Inc. | 18 | $188 |
| Lilly USA, LLC | 4 | $95 |
| Takeda Pharmaceuticals U.S.A., Inc. | 3 | $86 |
| CSL Behring | 3 | $59 |
| Novartis Pharmaceuticals Corporation | 3 | $53 |
| PFIZER INC. | 2 | $40 |
| GENZYME CORPORATION | 2 | $38 |
| Grifols USA, LLC | 2 | $36 |
Products named: NUCALA, DUPIXENT, TEZSPIRE, EBGLYSS, AIRSUPRA, Hizentra, Rhapsido, BREZTRI.
Industry payments across CO — which companies pay providers there.
